Lixte Biotechnology Holdings Inc Financial Flexibility Index
Lixte Biotechnology Holdings Inc financial flexibility index. Lixte Biotechnology Holdings Inc (LIXT) has a Financial Flexibility Index of -1.07x as of March 2026. Free cash flow of $-1.81 Million (operating CF $-1.83 Million minus capex $24.86K) represents -1% of total liabilities ($1.69 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Lixte Biotechnology Holdings Inc (2005–2025)
Financial flexibility index of Lixte Biotechnology Holdings Inc from 2005 to 2025. Historical Financial Flexibility Index trend for Lixte Biotechnology Holdings Inc across 21 annual periods. Check Lixte Biotechnology Holdings Inc cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Lixte Biotechnology Holdings Inc Financial Flexibility Index by Year (2005–2025)
Lixte Biotechnology Holdings Inc financial flexibility index by year from 2005 to 2025. Year-by-year free cash flow to debt coverage for Lixte Biotechnology Holdings Inc. For the full cash flow conversion analysis, see LIXT cash generation efficiency.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.73x | $-3.07 Million | $-3.07 Million | $1.77 Million | ▲ +82.6% |
| 2024 | -9.94x | $-3.16 Million | $-3.16 Million | $318.28K | ▲ +27.3% |
| 2023 | -13.68x | $-4.29 Million | $-4.29 Million | $313.86K | ▼ -17.1% |
| 2022 | -11.68x | $-4.61 Million | $-4.61 Million | $394.79K | ▲ +14.6% |
| 2021 | -13.68x | $-4.14 Million | $-4.14 Million | $302.93K | ▼ -38.9% |
| 2020 | -9.84x | $-2.13 Million | $-2.13 Million | $216.52K | ▼ -39.9% |
| 2019 | -7.04x | $-1.67 Million | $-1.67 Million | $237.90K | ▲ +1.8% |
| 2018 | -7.16x | $-1.51 Million | $-1.51 Million | $210.91K | ▼ -89.2% |
| 2017 | -3.79x | $-1.41 Million | $-1.41 Million | $373.02K | ▲ +50.7% |
| 2016 | -7.67x | $-1.68 Million | $-1.68 Million | $218.65K | ▼ -0.5% |
| 2015 | -7.64x | $-2.18 Million | $-2.18 Million | $285.64K | ▼ -27.7% |
| 2014 | -5.98x | $-1.64 Million | $-1.64 Million | $273.44K | ▼ -63.1% |
| 2013 | -3.67x | $-1.18 Million | $-1.18 Million | $321.77K | ▲ +20.6% |
| 2012 | -4.62x | $-1.21 Million | $-1.21 Million | $261.15K | ▼ -19.1% |
| 2011 | -3.88x | $-1.36 Million | $-1.36 Million | $350.75K | ▲ +19.2% |
| 2010 | -4.80x | $-936.39K | $-936.39K | $195.06K | ▼ -125.8% |
| 2009 | -2.13x | $-638.44K | $-638.44K | $300.26K | ▼ -33.5% |
| 2008 | -1.59x | $-597.69K | $-597.69K | $375.20K | ▲ +42.8% |
| 2007 | -2.79x | $-702.60K | $-702.87K | $252.18K | ▲ +21.7% |
| 2006 | -3.56x | $-442.95K | $-443.45K | $124.50K | ▼ -35.3% |
| 2005 | -2.63x | $-32.87K | $-32.87K | $12.50K | — |